1,2-dipalmitoylphosphatidylcholine has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliakbari, F; Bardania, H; Becker, S; Christiansen, G; Collingwood, JF; Dehghani Esmatabad, F; Eslampanah Seyedi, HA; Mohammad-Beigi, H; Morshedi, D; Otzen, DE; Rezaei-Ghaleh, N; Tayaranian Marvian, A; Zweckstetter, M | 1 |
1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Parkinson Disease
| Article | Year |
|---|---|
The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in Parkinson's Disease.
Topics: 1,2-Dipalmitoylphosphatidylcholine; alpha-Synuclein; Animals; Calcium; Cholesterol; Humans; Liposomes; Nanoparticles; Neurons; Parkinson Disease; PC12 Cells; Polyethylene Glycols; Rats; Reactive Oxygen Species | 2018 |